| Sattva S. Neelapu, M.D. |
Present Title & Affiliation
Primary Appointment
Assistant Professor, Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education | |
| 1991 | Jawaharlal Institute of Post-Graduate Medical Education and Research, Pondicherry, India, M.B., B.S., Medicine |
Postgraduate Training | |
| 7/2001-3/2004 | Postdoctoral Fellowship, Tumor Immunology, National Cancer Institute, National Institutes of Health, Bethesda, MD |
| 7/1998-6/2001 | Clinical Fellowship, Medical Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD |
| 7/1992-6/1995 | Clinical Residency, Internal Medicine, Coney Island Hospital, Brooklyn, NY |
Board Certifications
| 2000 | American Board of Internal Medicine, Medical Oncology |
| 1995 | American Board of Internal Medicine, Internal Medicine |
Selected Publications
Peer-Reviewed Original Research Articles | |
| 1. | Park HJ, Neelapu SS. Developing idiotype vaccines for lymphoma: From preclinical studies to Phase III clinical trials. Br J Haematol 142((2)):179-91, 7/2008. e-Pub 4/2008. NIHMSID: NIHMS41463. |
| 2. | Lee ST, Liu S, Radvanyi L, Sukhumalchandra P, Molldrem JJ, Wieder ED, Hwu P, Liu YJ, Kwak LW, Lizée G, Neelapu SS. A novel strategy for rapid and efficient isolation of human tumor-specific CD4(+) and CD8(+) T-cell clones. J Immunol Methods 331(1-2):13-26, 2/2008. e-Pub 10/2007. PMCID: PMC2265521. |
| 3. | Neelapu SS, Gause BL, Harvey L, Lee ST, Frye AR, Horton J, Robb RJ, Popescu MC, Kwak LW. A novel proteoliposomal vaccine induces antitumor immunity against follicular lymphoma. Blood 109(12):5160-3, 6/2007. e-Pub 3/2007. PMID: 17339422. |
| 4. | O'Mahony D, Morris JC, Quinn C, Gao W, Wilson WH, Gause B, Pittaluga S, Neelapu S, Brown M, Fleisher TA, Gulley JL, Schlom J, Nussenblatt R, Albert P, Davis TA, Lowy I, Petrus M, Waldmann TA, Janik JE. A Pilot Study of CTLA-4 blockade after cancer vaccine failure in patients with advanced malignancy. Clin Cancer Res 13(3):958-964, 2/2007. PMID: 17289891. |
| 5. | Neelapu SS, Kwak LW, Kobrin CB, Reynolds CW, Janik JE, Dunleavy K, White T, Harvey L, Pennington R, Stetler-Stevenson M, Jaffe ES, Steinberg SM, Gress R, Hakim F, Wilson WH. Vaccine-induced tumor-specific immunity despite severe B-cell depletion in mantle cell lymphoma. Nat Med 11(9):986-91, 9/2005. PMID: 16116429. |
| 6. | Neelapu SS, Munshi NC, Jagannath S, Watson TM, Pennington R, Reynolds C, Barlogie B, Kwak LW. Tumor antigen immunization of sibling stem cell transplant donors in multiple myeloma. Bone Marrow Transplant 36(4):315-23, 8/2005. PMID: 15968284. |
| 7. | Neelapu SS, Baskar S, Gause BL, Kobrin CB, Watson TM, Frye AR, Pennington R, Harvey L, Jaffe ES, Robb RJ, Popescu MC, Kwak LW. Human autologous tumor-specific T-cell responses induced by liposomal delivery of a lymphoma antigen. Clin Cancer Res 10(24):8309-17, 12/2004. PMID: 15623607. |
Last updated: 9/2/2009
- Global Navigation
- About Us
- Locations
- Events
- Careers
- Publications
- How You Can Help
- Contact Us
- Newsroom
- Site Index
- Patient & Cancer Information
- myMDAnderson
- Cancer Information
- Patient Information
- Care Centers & Clinics
- Children’s Cancer Hospital
- Services & Amenities
- Physician Directory
- Education and Research
- Departments, Programs & Labs
- PeopleFinder
- Research at M.D Anderson
- Education & Training
- Resources for Professionals
- For Employees
- Employee Alerts
- Employee Resources
- Doing Business
- Vendors & Suppliers
- Partners & Affiliates
© 2009 The University of Texas M. D. Anderson Cancer Center

